Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics: A meta-analysis of randomized controlled trials.

Rajshekhar ChakrabortyRabbia SiddiqiGloria WillsonSamiksha GuptaNoureen AsgharMuhammad HusnainMohammed A AljamaTapas Ranjan BeheraFaiz AnwerAurore PerrotIrbaz B Riaz

Published in: Cancer (2022)

Upfront autologous stem cell transplantation improves overall survival in patients with newly diagnosed myeloma harboring high-risk cytogenetics.

Keyphrases

newly diagnosed
stem cell transplantation
multiple myeloma
high dose
cell therapy
bone marrow
free survival
platelet rich plasma
systematic review
stem cells